Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin vs lamotrigine monotherapy in newly diagnosed partial seizures
2005-004023-19Phase 3Completed
- Sponsor
- Pfizer
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy comparing Pregabalin monotherapy with Lamotrigine monotherapy (2 arms). Primary endpoint: Seizure-free rate for at least 6 months. Started Mar 2006; status: completed.
02
Drugs
pregabalinlamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2005-004023-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004023-19.